Retropubic radical prostatectomy is the most commonly used therapeutic option for the
treatment of clinically localized prostate cancer. An ongoing stage migration toward organ-…

There is substantial heterogeneity among primary prostate cancers, evident in the spectrum
of molecular abnormalities and its variable clinical course. As part of The Cancer Genome …

BACKGROUND: Although the initial robot-assisted radical prostatectomy (RARP) series
showed 12-mo potency rates ranging from 70% to 80%, the few available comparative studies …

CONTEXT: Despite the wide diffusion of laparoscopic radical prostatectomy (LRP) and robot-assisted
laparoscopic radical prostatectomy (RALP), only few studies comparing the results …

CONTEXT: Perioperative complications are a major surgical outcome for radical prostatectomy
(RP). OBJECTIVE: Evaluate complication rates following robot-assisted RP (RARP), risk …

CONTEXT: Detailed knowledge of the anatomy of the prostate and adjacent tissues is
mandatory during radical prostatectomy to ensure reliable oncologic and functional outcomes. …

CONTEXT: Despite the large diffusion of robot-assisted radical prostatectomy (RARP),
literature and data on the oncologic outcome of RARP are limited. OBJECTIVE: Evaluate lymph …

CONTEXT: The incidence of postoperative complications is still the most frequently used
surrogate marker of quality in surgery, but no standard guidelines or criteria exist for reporting …

CONTEXT: Pelvic lymph node dissection (PLND) is considered the most reliable procedure
for the detection of lymph node metastases in prostate cancer (PCa); however, the …

Prostate-specific membrane antigen (PSMA) overexpression theoretically enables targeting
of prostate cancer (PCa) metastases using gallium Ga 68 ( 68 Ga)–labeled PSMA ligands …